Non-familial restrictive cardiomyopathy

Non-familial restrictive cardiomyopathy is a form of restrictive cardiomyopathy (RCM) that occurs sporadically, meaning it arises without a clear hereditary or familial pattern. Restrictive cardiomyopathy is characterized by impaired filling of the heart ventricles due to increased stiffness of the heart muscle (myocardium), while the thickness of the ventricular walls and systolic function may remain relatively normal, at least in early stages. The stiff ventricles cannot relax and fill properly during diastole, leading to elevated filling pressures and subsequent symptoms of heart failure, including shortness of breath (dyspnea), fatigue, exercise intolerance, and fluid retention manifesting as peripheral edema and ascites. Atrial enlargement is a hallmark finding, and patients are at increased risk for atrial arrhythmias and thromboembolic events. The non-familial form is distinguished from hereditary forms of RCM, which may be caused by mutations in sarcomeric or other cardiac genes. In non-familial cases, the underlying etiology may be idiopathic (no identifiable cause) or may result from acquired conditions such as infiltrative diseases, storage disorders, or other secondary causes that have been excluded from the familial category. The condition primarily affects the cardiovascular system, but secondary effects on the lungs (pulmonary congestion), liver (hepatic congestion), and kidneys may occur as heart failure progresses. There is no specific curative treatment for non-familial restrictive cardiomyopathy. Management is largely supportive and focuses on controlling heart failure symptoms with diuretics, managing arrhythmias, and anticoagulation therapy to prevent thromboembolic complications. In advanced or refractory cases, heart transplantation may be considered and remains the definitive treatment option. Prognosis is generally guarded, as restrictive cardiomyopathy tends to be progressive, and outcomes depend on the underlying cause and the severity of diastolic dysfunction at diagnosis.

Common questions about Non-familial restrictive cardiomyopathy